- Home
- PVL vs NTRB Comparison
PVL vs NTRB Comparison
Compare PVL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PVL | NTRB |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 71.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PVL | NTRB |
|---|---|---|
| Price | $1.82 | $4.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 75.3K | 23.0K |
| Earning Date | 01-01-0001 | 12-11-2025 |
| Dividend Yield | ★ 20.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $3,511,891.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $27.95 | ★ N/A |
| Revenue Growth | 11.77 | ★ 12.69 |
| 52 Week Low | $1.30 | $3.72 |
| 52 Week High | $2.04 | $11.78 |
Technical Indicators
Market Signals| Indicator | PVL | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 34.48 |
| Support Level | $1.78 | $4.60 |
| Resistance Level | $1.90 | $5.45 |
| Average True Range (ATR) | 0.05 | 0.39 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 43.86 | 12.69 |
Price Performance
Historical ComparisonAbout PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.